Document text
Principal Investigator: Monica Rosas Lemus
Organization: UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
Fiscal Year: 2024
Award: $231,004
Funding agency: National Institute of General Medical Sciences
SARS-CoV-2 caused the COVID-19 pandemic and millions of deaths worldwide. Although vaccines were developed in record time, the natural cycle of immunity is short and the rise of new variants complicates the development of herd immunity. New drugs have been proposed as antivirals however, it is known that viruses also develop drug resistance. Therefore, it is necessary to find new therapeutic targets to cope with SARS-CoV-2 and new zoonotic coronaviruses to prevent new pandemics and another global health crisis. In this regard, a proven therapeutic target that is understudied is the inhibition of viral capping, a process that modifies the 5’UTR of the viral RNA to mimic the mammalian RNA. Capping prevents the degradation of viral RNA, improves translation, and prevents the detection of the innate cell immune system. Viral replication and capping take place in confined double-membrane vesicles (DMV) formed by host membranes and viral non-structural proteins (nsps). These processes cause severe stress and imbalance in the metabolism and bioenergetics of the host cell since high amounts of ATP and S-adenosylmethionine are used. Many metabolic pathways improve their efficiency by forming protein complexes, which avoid product inhibition and move the equilibrium of the reaction to the product. The replication-transcriptional (RTC) complex of SARS-CoV-2 was previously described; however little is known about the capping enzymes (nsp14-nsp10, nsp16-nsp10). Since capping enzymes are methyl transferases (MTases), which are strongly inhibited by the product of the reaction S-adenosylhomocysteine (SAH), and this product can only be hydrolyzed by a host SAH-hydrolase (AHCY), the need for host metabolites such as ATP, GTP,SAM and SAH hydrolysis, indicates a possible viral-host hybrid metabolon which is unknown. The overall goal of this proposal is to determine the existence of a hybrid viral-capping-host metabolic pool within the DMVs and the impact of these changes on the bioenergetics of the host. To address these knowledge gaps, we will take an integrated strategy using computational, biochemical, structural, and cell biology approaches. The aims of the proposal are: 1. Determine the existence of a viral methyltransferases-SAH hydrolase metabolon. Using AlphaFold 2 multimer software as a computational approach to predict the interactions of the methyl transferases nsp14-nsp16-nsp10 and nsp14, nsp16, nsp10 with AHCY. In parallel, these interactions will be tested by pull-down assays, using purified proteins and structural biology. Aim 2. Establish the localization of the methyltransferases from coronaviruses and S-adenosylmethionine hydrolase within the DMVs. The co-localization of capping enzymes nsp14, nsp16, and AHCY hydrolase within viral vesicles will be assessed by a time-course of MHV infection using lung-rat epithelial cells (L2), followed by subcellular fractionation, Co-immunoprecipitation as well as confocal microscopy using immunofluorescence. Aim 3. Assess the changes in the glycolysis and oxidative phosphorylation of the host upon viral replication and capping. The rate of external acidification (glycolysis-lactate production) and the rate of oxygen consumption (mitochondrial activity) will be measured in L2-MHV-infected cells using a seahorse analyzer. And the interaction of the glycolytic enzymes and mitochondria with SAM-metabolic enzymes and viral proteins in the DMV, will be tested as in aim 2.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><5' Untranslated Regions><5'UTR><Address><Ademetionine><Adenosylhomocysteinase><AdoMet><Anti-viral Agents><Assay><Autophagocytosis><Bioassay><Biochemical><Bioenergetics><Biological Assay><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 virus><COVID-19 years><COVID19 virus><Cell Body><Cell Fractionation><Cells><Cellular biology><Cessation of life><Co-Immunoprecipitations><CoV-2><CoV2><Common Rat Strains><Complex><Computer software><Confocal Microscopy><Coronaviridae><Coronavirus><Death><Detection><Development><Disease><Disorder><EC 2.1.1><Enzyme Gene><Enzymes><Epithelial Cells><Equilibrium><GTP><Gene Transcription><Genetic Transcription><Genus Hippocampus><Glycolysis><Goals><Guanosine Triphosphate><Herd Immunity><Hybrids><Hydrolase><Hydrolase Family Gene><Hydrolase Gene><Hydrolysis><Immune system><Immunity><Immunofluorescence><Immunofluorescence Immunologic><Infection><Inflammation><Intermediary Metabolism><Knowledge><Lung><Lung Respiratory System><Measures><Membrane><Metabolic><Metabolic Pathway><Metabolic Processes><Metabolism><Methyltransferase><Mitochondria><NS Proteins><Non-Polyadenylated RNA><Oxidative Phosphorylation><Oxidative Phosphorylation Pathway><Oxygen Consumption><Phase><Process><Production><RNA><RNA Expression><RNA Gene Products><Rat><Rats Mammals><Rattus><Reaction><Ribonucleic Acid><S-Adenosylhomocysteine><S-Adenosylmethionine><S-adenosyl methionine><S-adenosyl-methionine><S-adenosylhomocysteine Hydrolase><S-adenosylhomocysteine Synthase><SAH Hydrolase><SAMe><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Seahorse><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Software><Stress><Testing><Time><Transcription><Transferase><Transferase Gene><Translations><Vaccines><Variant><Variation><Vesicle><Viral><Viral Gene Products><Viral Gene Proteins><Viral Nonstructural Proteins><Viral Proteins><Virus><Virus Replication><Wuhan coronavirus><anti-viral compound><anti-viral drugs><anti-viral medication><anti-viral therapeutic><anti-virals><autophagy><balance><balance function><cell biology><coping><corona virus><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 virus><develop drug resistance><developmental><drug resistance development><emergent pandemic><emerging pandemic><global health><hCoV19><improved><mRNA Leader Sequences><membrane structure><methylase><mitochondrial><nCoV2><new drug target><new drug treatments><new druggable target><new drugs><new pandemic><new pharmacological therapeutic><new pharmacotherapy target><new therapeutic target><new therapeutics><new therapy><new therapy target><next generation therapeutics><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pandemic><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel pharmacotherapy target><novel therapeutic target><novel therapeutics><novel therapy><novel therapy target><prevent><preventing><protein complex><protein purification><pulmonary><s-adenosyl-l-methionine><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><structural biology><subcellular fractionation><therapeutic target><translation><transmethylase><viral RNA><viral multiplication><viral replication><virus RNA><virus multiplication><virus protein><zoonotic CoV><zoonotic coronavirus>